Potential Side Effects and Risks Common side effects may include nausea, diarrhea, and abdominal pain, but these often diminish
A real-world study with 769 Korean people with obesity, body weight and BMI decreased significantly after initiation of liraglutide 3.0 mg treatment: 2.94 kg and 1.08 kg/m 2 at 2 months
Consistency is Key: Regular use of semaglutide GLP-1, along with following a balanced diet and exercise routine, can help maintain long-term appetite control
Diabetic Retinopathy - Complications of diabetic retinopathy in Semaglutide clinical trials have been seen only in patients with type 2 diabetes mellitus and those with a body mass index corresponding to being overweight
Nat Rev Gastroenterol Hepatol 8:202211 Miller RP, Roberts RJ, Fischer LJ (1976) Acetaminophen elimination kinetics in neonates, children, and adults